GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Paion Ag (OTCPK:PAIOF) » Definitions » Operating Margin %

Paion Ag (Paion Ag) Operating Margin % : -114.60% (As of Jun. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Paion Ag Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Paion Ag's Operating Income for the six months ended in Jun. 2023 was $-8.43 Mil. Paion Ag's Revenue for the six months ended in Jun. 2023 was $7.36 Mil. Therefore, Paion Ag's Operating Margin % for the quarter that ended in Jun. 2023 was -114.60%.

The historical rank and industry rank for Paion Ag's Operating Margin % or its related term are showing as below:

PAIOF' s Operating Margin % Range Over the Past 10 Years
Min: -48684.72   Med: -291.43   Max: 9.38
Current: -118.22


PAIOF's Operating Margin % is ranked worse than
88.41% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 6.075 vs PAIOF: -118.22

Paion Ag's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Paion Ag's Operating Income for the six months ended in Jun. 2023 was $-8.43 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2023 was $-18.73 Mil.

Warning Sign:

Paion Ag has recorded a loss in operating income at least once over the past 3 years.


Paion Ag Operating Margin % Historical Data

The historical data trend for Paion Ag's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paion Ag Operating Margin % Chart

Paion Ag Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -463.04 -126.53 9.38 -309.76 4.53

Paion Ag Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -234.10 -387.70 44.51 -121.29 -114.60

Competitive Comparison of Paion Ag's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Paion Ag's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paion Ag's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Paion Ag's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Paion Ag's Operating Margin % falls into.



Paion Ag Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Paion Ag's Operating Margin % for the fiscal year that ended in Dec. 2022 is calculated as

Operating Margin %=Operating Income (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=1.594 / 35.22
=4.53 %

Paion Ag's Operating Margin % for the quarter that ended in Jun. 2023 is calculated as

Operating Margin %=Operating Income (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=-8.43 / 7.356
=-114.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paion Ag  (OTCPK:PAIOF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Paion Ag Operating Margin % Related Terms

Thank you for viewing the detailed overview of Paion Ag's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Paion Ag (Paion Ag) Business Description

Traded in Other Exchanges
Address
Heussstrasse 25, Aachen, DEU, 52078
Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.